A Four-Week Double Blind Multicenter Study Comparing The Efficacy And Safety Of Ziprasidone To Aripiprazole In Subjects With Schizophrenia Or Schizoaffective Disorder Needing Inpatient Care

简要总结

主要结局

次要结局

• Change from baseline to Days 2, 4, 7, 14, 21, and 28 in Positive and Negative Syndrome Scale (PANSS) positive subscale scores.(28 days)
• Change from baseline to Days 2, 4, 7, 14, 21, and 28 in PANSS negative subscale scores.(28 days)
• Change from baseline to Days 2, 4, 7, 14, 21, and 28 in PANSS Depression factor scores.(28 days)
• Change from baseline to Days 2, 4, 7, 14, 21, and 28 in COVI Anxiety Scale scores.(28 days)
• Change from baseline to endpoint in Patient Preference Scale (PPS) scores.(28 days)
• Change from baseline to endpoint in Calgary Depression Scale for Schizophrenia (CDSS) scores.(28 days)
• Change from baseline to endpoint in Personal Evaluation of Transition in Treatment (PETiT) scale scores.(28 days)
• Change from baseline to endpoint in Global Assessment of Functioning (GAF) scale scores.(28 days)
• Change from baseline to endpoint in Drug Attitude Inventory (DAI) scores.(28 days)
• Change from baseline to endpoint in Life Skills Profile (LSP).(28 days)
• Change from baseline to Days 2, 4, 7, 14, 21, and 28 in PANSS total scores.(28 days)
• Change from baseline to Days 2, 4, 7, 14, 21, and 28 in Clinical Global Impressions-Improvement (CGI-I) scale scores.(28 days)
• Adverse events, laboratory evaluations, vital signs, electrocardiograms at baseline and on Days 2, 4, 7, 14, 21, and 28.(28 days)
• Change from baseline in Outcome Resource Discharge Questionnaire (ORDQ) scores on Days 2, 4, 7, 14, 21, and 28.(28 days)
• Change from baseline to endpoint in Cognitive Battery.(28 days)
• Change from baseline to Day 28 in movement disorder rating scale scores.(28 days)